Eli Lilly (LLY) Q1 earnings 2023


Eli Lilly CEO David Ricks on Q1 earnings: This will be a year of both growth and investment

Eli Lilly‘s first-quarter earnings missed expectations Thursday, but the pharmaceutical company raised its full-year guidance.

Before the earnings release, the company also reported positive data on its weight loss drug tirzepatide.

Eli Lilly shares rose more than 3% in morning trading.

The company’s revenue fell 11% compared with the same quarter last year, due to a $1.5 billion decline in sales from its Covid-19 antibodies. Lilly reported $6.96 billion in revenue for the quarter, which slightly topped analysts’ expectations, but sales declined from $7.81 billion in the prior-year quarter.

The company posted adjusted earnings of $1.62 per share, which missed analyst expectations of $1.73 a…

Source cnbc.com

0 0 votes
Article Rating

Hamptons home prices hit a record $3 million in the first quarter

Previous article

U.S. GDP rose at a 1.1% pace in the first quarter as signs build that the economy is slowing

Next article

You may also like

Notify of
Inline Feedbacks
View all comments

More in Earnings